1. Home
  2. ASYS vs SLN Comparison

ASYS vs SLN Comparison

Compare ASYS & SLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amtech Systems Inc.

ASYS

Amtech Systems Inc.

HOLD

Current Price

$18.80

Market Cap

341.5M

Sector

Technology

ML Signal

HOLD

Logo Silence Therapeutics Plc American Depository Share

SLN

Silence Therapeutics Plc American Depository Share

HOLD

Current Price

$10.39

Market Cap

300.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASYS
SLN
Founded
1981
1994
Country
United States
United Kingdom
Employees
N/A
88
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
341.5M
300.9M
IPO Year
2006
N/A

Fundamental Metrics

Financial Performance
Metric
ASYS
SLN
Price
$18.80
$10.39
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$42.60
AVG Volume (30 Days)
531.0K
559.5K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.09
N/A
Revenue
$79,364,000.00
N/A
Revenue This Year
$2.82
N/A
Revenue Next Year
$18.75
N/A
P/E Ratio
$208.89
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.30
$4.19
52 Week High
$25.71
$11.06

Technical Indicators

Market Signals
Indicator
ASYS
SLN
Relative Strength Index (RSI) 44.82 71.89
Support Level $17.48 $5.87
Resistance Level $24.70 N/A
Average True Range (ATR) 2.11 0.80
MACD -0.25 0.37
Stochastic Oscillator 6.88 85.24

Price Performance

Historical Comparison
ASYS
SLN

About ASYS Amtech Systems Inc.

Amtech Systems Inc provides equipment, consumables and services for semiconductor device packaging, wafer production and device fabrication. Its products are used to fabricate and package GPUs for AI applications, SiC and Si power devices, and other optical, analog and digital devices, and are sold to semiconductor packaging, electronic assembly and device fabrication companies. It operates through two segments: Thermal Processing Solutions, which includes conveyorized reflow equipment, high-temperature conveyorized furnaces and diffusion furnaces with maximum revenue; and Semiconductor Fabrication Solutions, which includes consumables, equipment and services for wafer polishing, dicing and cleaning. The majority of revenue is derived from the United States.

About SLN Silence Therapeutics Plc American Depository Share

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA. Using its mRNAi GOLD platform, the company has generated siRNA product candidates both for its internal development pipeline as well as for out-licensed programs with third-party collaborators. Its wholly owned pipeline is focused on three therapeutic areas: cardiovascular disease, hematology, and rare diseases. The different product candidates in its pipeline are Divesiran (SLN124), a siRNA product candidate that has the potential to treat several hematological disorders; Zerlasiran (SLN360), being developed as a potential treatment to reduce cardiovascular issues; SLN-312; SLN-548; and multiple other programs.

Share on Social Networks: